Enhancement of non-Candida antibody responses by Candida albicans cell wall glycoprotein. 1987

J E Domer, and K L Elkins, and D L Ennist, and P W Stashak, and R E Garner, and P J Baker
Department of Microbiology and Immunology, Tulane Medical School, New Orleans, Louisiana 70112.

Two cell wall glycoprotein extracts from Candida albicans (glycoprotein [GP] and peptidoglucomannan [PGM]) were tested for their influence on antibody responses to type III pneumococcal polysaccharide and sheep erythrocytes. GP was isolated from lipid-extracted cell walls with ethylenediamine, whereas PGM was extracted with dilute sodium hydroxide. Both glycoproteins increased the number of antibody-producing plaque-forming cells in the spleens of mice immunized with type III polysaccharide or sheep erythrocytes, although PGM appeared to be about 10 times more effective. PGM could be administered up to 3 days prior to immunization with sheep erythrocytes to elicit enhancement; it did not have to be administered by the same route as the immunogen to cause significant enhancement. Enhancement did not appear to be the result of a direct mitogenic effect of GP and PGM on lymphocytes, nor did these glycoproteins appear to stimulate the production of B-cell growth factors or interleukin 2.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005656 Fungal Proteins Proteins found in any species of fungus. Fungal Gene Products,Fungal Gene Proteins,Fungal Peptides,Gene Products, Fungal,Yeast Proteins,Gene Proteins, Fungal,Peptides, Fungal,Proteins, Fungal
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated

Related Publications

J E Domer, and K L Elkins, and D L Ennist, and P W Stashak, and R E Garner, and P J Baker
July 2004, FEMS immunology and medical microbiology,
J E Domer, and K L Elkins, and D L Ennist, and P W Stashak, and R E Garner, and P J Baker
January 1979, Toxicon : official journal of the International Society on Toxinology,
J E Domer, and K L Elkins, and D L Ennist, and P W Stashak, and R E Garner, and P J Baker
December 2018, Journal of oral science,
J E Domer, and K L Elkins, and D L Ennist, and P W Stashak, and R E Garner, and P J Baker
July 1985, Infection and immunity,
J E Domer, and K L Elkins, and D L Ennist, and P W Stashak, and R E Garner, and P J Baker
September 2008, Microbiology and molecular biology reviews : MMBR,
J E Domer, and K L Elkins, and D L Ennist, and P W Stashak, and R E Garner, and P J Baker
October 1986, Infection and immunity,
J E Domer, and K L Elkins, and D L Ennist, and P W Stashak, and R E Garner, and P J Baker
December 1982, Infection and immunity,
J E Domer, and K L Elkins, and D L Ennist, and P W Stashak, and R E Garner, and P J Baker
October 1983, Canadian journal of microbiology,
J E Domer, and K L Elkins, and D L Ennist, and P W Stashak, and R E Garner, and P J Baker
January 2001, Microbios,
J E Domer, and K L Elkins, and D L Ennist, and P W Stashak, and R E Garner, and P J Baker
July 1989, Journal of chemotherapy (Florence, Italy),
Copied contents to your clipboard!